Castle Biosciences, Inc. (CSTL)

USD 19.7

(2.07%)

Net Debt Summary of Castle Biosciences, Inc.

  • Castle Biosciences, Inc.'s latest annual net debt in 2023 was -83.53 Million USD , up 23.81% from previous year.
  • Castle Biosciences, Inc.'s latest quarterly net debt in 2024 Q1 was -57.89 Million USD , up 30.69% from previous quarter.
  • Castle Biosciences, Inc. reported annual net debt of -109.63 Million USD in 2022, up 65.9% from previous year.
  • Castle Biosciences, Inc. reported annual net debt of -321.55 Million USD in 2021, up 21.54% from previous year.
  • Castle Biosciences, Inc. reported quarterly net debt of -57.89 Million USD for 2024 Q1, up 30.69% from previous quarter.
  • Castle Biosciences, Inc. reported quarterly net debt of -60.38 Million USD for 2024 Q2, down -4.29% from previous quarter.

Annual Net Debt Chart of Castle Biosciences, Inc. (2023 - 2017)

Historical Annual Net Debt of Castle Biosciences, Inc. (2023 - 2017)

Year Net Debt Net Debt Growth
2023 -83.53 Million USD 23.81%
2022 -109.63 Million USD 65.9%
2021 -321.55 Million USD 21.54%
2020 -409.85 Million USD -455.94%
2019 -73.72 Million USD -468.22%
2018 20.02 Million USD 15.13%
2017 17.39 Million USD 0.0%

Peer Net Debt Comparison of Castle Biosciences, Inc.

Name Net Debt Net Debt Difference
Aclaris Therapeutics, Inc. -39.45 Million USD -111.728%
Applied DNA Sciences, Inc. -5.91 Million USD -1312.419%
Aspira Women's Health Inc. -331 Thousand USD -25135.952%
Biodesix, Inc. 34.3 Million USD 343.481%
BioNexus Gene Lab Corp. -5.79 Million USD -1341.198%
bioAffinity Technologies, Inc. -1.24 Million USD -6620.486%
bioAffinity Technologies, Inc. -1.24 Million USD -6620.486%
Bionano Genomics, Inc. 34.88 Million USD 339.467%
CareDx, Inc -47.97 Million USD -74.11%
Check-Cap Ltd. -24.75 Million USD -237.417%
DarioHealth Corp. -7.54 Million USD -1006.664%
Exact Sciences Corporation 1.94 Billion USD 104.285%
Fulgent Genetics, Inc. -82.56 Million USD -1.169%
Guardant Health, Inc. 220.22 Million USD 137.93%
ICON Public Limited Company 3.56 Billion USD 102.346%
IDEXX Laboratories, Inc. 493.94 Million USD 116.911%
Illumina, Inc. 1.21 Billion USD 106.881%
Intelligent Bio Solutions Inc. -5.43 Million USD -1437.571%
iSpecimen Inc. -2.14 Million USD -3789.827%
Standard BioTools Inc. 46.5 Million USD 279.613%
MDxHealth SA 18.88 Million USD 542.314%
23andMe Holding Co. -141.37 Million USD 40.914%
Medpace Holdings, Inc. -103.32 Million USD 19.159%
Myriad Genetics, Inc. 88.1 Million USD 194.814%
Mainz Biomed B.V. 349.85 Thousand USD 23975.891%
ENDRA Life Sciences Inc. -2.43 Million USD -3324.098%
NeoGenomics, Inc. 269.19 Million USD 131.03%
Neogen Corporation 735.62 Million USD 111.355%
Inotiv, Inc. 382.14 Million USD 121.858%
Natera, Inc. -200.1 Million USD 58.256%
OpGen, Inc. 11.89 Million USD 802.42%
OPKO Health, Inc. 230.68 Million USD 136.21%
Psychemedics Corporation 334 Thousand USD 25109.281%
Prenetics Global Limited -43.33 Million USD -92.747%
Prenetics Global Limited -43.33 Million USD -92.747%
Precipio, Inc. -386 Thousand USD -21540.155%
Personalis, Inc. -8.02 Million USD -941.274%
RadNet, Inc. 1.14 Billion USD 107.273%
Sera Prognostics, Inc. -2.02 Million USD -4031.108%
Sotera Health Company 2.02 Billion USD 104.124%
Neuronetics, Inc. 2.79 Million USD 3086.45%
Star Equity Holdings, Inc. -15.33 Million USD -444.637%
Star Equity Holdings, Inc. -15.33 Million USD -444.637%
Trinity Biotech plc 63.73 Million USD 231.058%
T2 Biosystems, Inc. 33.8 Million USD 347.067%
Twist Bioscience Corporation -192.4 Million USD 56.585%
Exagen Inc. -12.77 Million USD -554.017%